Bear of the Day: Krispy Kreme (DNUT)

Krispy Kreme (DNUT) now carries a Zacks Rank #5 (Strong Sell), the lowest rating in the Zacks system, following a downgrade tied to what the research firm calls multiple structural challenges.

The headline pressure is demand. Zacks points to rising GLP-1 weight-loss drug adoption, citing studies showing sweet bakery purchases fall nearly 10% once patients start these medications. For a company selling sugary baked goods, that is a direct hit to its core category.

The financial picture compounds the problem. Zacks flags negative revenue growth projections through 2027. The balance sheet has weakened, with debt-to-equity ratios nearly tripling since 2022. DNUT shares have dropped 78.8% over five years, a record of persistent underperformance.

The stock also trades below $3. Zacks argues that price level deters institutional investors, which limits a natural source of buying support.

Interpretation: the combination of shrinking top-line expectations and rising leverage leaves little room for error, and the sub-$3 price may amplify volatility on any negative news. No comparable downgrade was cited for McDonald's (MCD), so this reads as a name-specific call rather than a sector-wide verdict.